Vicor Technologies Announces Exclusive Distribution Agreement for its PD2i® Products in Israel
David H. Fater, CEO of Vicor Technologies, Inc., today announced that the Company has entered into an agreement with Hadar Training and Medical Services
News
Freedom Meditech develops non-invasive Method to Monitor Glucose Levels
Freedom Meditech is a specialized medical devices company that is developing eye-based diabetes diagnosing and glucose monitoring. The current method of finger pricking for measuring […]
Exosome Diagnostics Develops Unique Genetic Based Diagnostics
Exosome Diagnostics is a specialized bio-pharmaceutical company that develops a unique kind of genetic-based diagnostic tests. The company’s technological platform isolates from the blood micro-vesicles […]
NimoGel™ Shows Promise at Preventing Delayed Complications of Sudden Brain Injury in a Preclinical Study
Contrary to popular belief, New Jersey has many hidden treasures and now Edge Therapeutics, a Newark, New Jersey based biopharmaceutical company has made tremendous headway in their quest for a cure for debilitating and potentially fatal brain injuries.
NeoGenomics Reports Fourth Quarter and Full Year 2010 Results
FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ — NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010.
Mobisante Wins FDA Approval For The World’s First smartphone-based ultrasound imaging system
Mobisante, Inc., a privately held medical device company located in Redmond, WA, announced recently that it has received 510(k) clearance from the FDA for its smartphone-based ultrasound imaging system, MobiUS.
Interface Biologics Appoints Art Rosenthal to Chairman of its Board of Directors
Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products recently announced the appointment of Arthur L. Rosenthal to Chairman of its Board of Directors.
ADVENTRX Pharmaceuticals Provides Update on ANX-514
ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary product candidates principally for the treatment of cancer, recently provided an update on its product candidate, ANX-514, its polysorbate 80-free formulation of docetaxel.
Small Bone Innovations Inc. Reports Significant Revenue Growth in 2010
Small Bone Innovations, Inc., an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair (arthroplasty) and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes, foot and ankle, recorded strong worldwide revenue growth of 24% for 2010 compared with 2009.
T-Ray Science Announces Name Change
T-Ray Science, Inc., a medical device company committed to commercializing innovative systems for the early detection of cancer announces that shareholders approved a change of the name of the Company to Verisante Technology, Inc.